Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -60.21% | -35.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -55.67% | -45.14% | |||
| Operating Income | 63.71% | 1.89% | |||
| Income Before Tax | 63.69% | 70.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 63.69% | 70.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.69% | 70.53% | |||
| EBIT | 63.71% | 1.89% | |||
| EBITDA | 65.15% | 1.88% | |||
| EPS Basic | 67.80% | 75.62% | |||
| Normalized Basic EPS | 67.57% | 21.28% | |||
| EPS Diluted | 73.97% | 69.83% | |||
| Normalized Diluted EPS | 67.57% | 21.28% | |||
| Average Basic Shares Outstanding | 12.69% | 20.67% | |||
| Average Diluted Shares Outstanding | 12.69% | 20.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
